
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 29, 2023, titled "Zydus announces IND clearance of a novel Anti-PCSK9 candidate".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated September 29, 2023, titled "Zydus announces IND clearance of a novel Anti-PCSK9 candidate".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences